Sanofi India Limited (SANOFI) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Sanofi India Limited (SANOFI) has a cash flow conversion efficiency ratio of 0.585x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs4.38 Billion ≈ $47.40 Million USD) by net assets (Rs7.49 Billion ≈ $81.02 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Sanofi India Limited (SANOFI) net asset quality to measure how much of total assets are equity-financed.
Sanofi India Limited - Cash Flow Conversion Efficiency Trend (2004–2025)
This chart illustrates how Sanofi India Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check cash flow quality index of Sanofi India Limited to evaluate the quality of earnings relative to operating cash generation.
Sanofi India Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Sanofi India Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Clinica Baviera
MC:CBAV
|
0.146x |
|
Newonder Special Electric Co.Ltd
SHE:301120
|
-0.003x |
|
Montepino Logistica SOCIMI S.A.
PA:MLMTP
|
N/A |
|
Fujian Longxi Bearing Group Co Ltd
SHG:600592
|
0.011x |
|
Sparekassen Sjaelland-Fyn A/S
CO:SPKSJF
|
0.107x |
|
Corsair Gaming Inc
NASDAQ:CRSR
|
0.045x |
|
Saul Centers Inc
NYSE:BFS
|
0.062x |
|
Sichuan Shudao Equipment & Technology Co Ltd
SHE:300540
|
-0.073x |
Annual Cash Flow Conversion Efficiency for Sanofi India Limited (2004–2025)
The table below shows the annual cash flow conversion efficiency of Sanofi India Limited from 2004 to 2025. For the full company profile with market capitalisation and key ratios, see Sanofi India Limited stock valuation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | Rs7.49 Billion ≈ $81.02 Million |
Rs4.51 Billion ≈ $48.76 Million |
0.602x | +12.23% |
| 2024-12-31 | Rs8.61 Billion ≈ $93.07 Million |
Rs4.62 Billion ≈ $49.91 Million |
0.536x | +136.29% |
| 2023-12-31 | Rs10.15 Billion ≈ $109.79 Million |
Rs2.30 Billion ≈ $24.92 Million |
0.227x | -27.38% |
| 2022-12-31 | Rs12.76 Billion ≈ $137.97 Million |
Rs3.99 Billion ≈ $43.12 Million |
0.313x | +24.47% |
| 2021-12-31 | Rs22.26 Billion ≈ $240.69 Million |
Rs5.59 Billion ≈ $60.43 Million |
0.251x | -12.94% |
| 2020-12-31 | Rs21.19 Billion ≈ $229.16 Million |
Rs6.11 Billion ≈ $66.09 Million |
0.288x | +70.83% |
| 2019-12-31 | Rs24.42 Billion ≈ $264.13 Million |
Rs4.12 Billion ≈ $44.59 Million |
0.169x | +0.20% |
| 2018-12-31 | Rs22.19 Billion ≈ $240.00 Million |
Rs3.74 Billion ≈ $40.44 Million |
0.168x | -21.53% |
| 2017-12-31 | Rs20.26 Billion ≈ $219.15 Million |
Rs4.35 Billion ≈ $47.05 Million |
0.215x | +15.52% |
| 2016-12-31 | Rs17.36 Billion ≈ $187.70 Million |
Rs3.23 Billion ≈ $34.89 Million |
0.186x | +41.87% |
| 2015-12-31 | Rs16.27 Billion ≈ $175.97 Million |
Rs2.13 Billion ≈ $23.05 Million |
0.131x | -26.53% |
| 2014-12-31 | Rs14.86 Billion ≈ $160.69 Million |
Rs2.65 Billion ≈ $28.65 Million |
0.178x | -11.89% |
| 2013-12-31 | Rs13.47 Billion ≈ $145.64 Million |
Rs2.73 Billion ≈ $29.48 Million |
0.202x | -14.90% |
| 2012-12-31 | Rs12.04 Billion ≈ $130.22 Million |
Rs2.86 Billion ≈ $30.97 Million |
0.238x | +29.53% |
| 2011-12-31 | Rs11.17 Billion ≈ $120.76 Million |
Rs2.05 Billion ≈ $22.17 Million |
0.184x | +42.45% |
| 2010-12-31 | Rs10.14 Billion ≈ $109.68 Million |
Rs1.31 Billion ≈ $14.14 Million |
0.129x | -12.71% |
| 2009-12-31 | Rs9.32 Billion ≈ $100.77 Million |
Rs1.38 Billion ≈ $14.88 Million |
0.148x | +2.28% |
| 2008-12-31 | Rs8.29 Billion ≈ $89.66 Million |
Rs1.20 Billion ≈ $12.95 Million |
0.144x | -1.97% |
| 2007-12-31 | Rs7.07 Billion ≈ $76.44 Million |
Rs1.04 Billion ≈ $11.26 Million |
0.147x | -27.73% |
| 2006-12-31 | Rs6.08 Billion ≈ $65.78 Million |
Rs1.24 Billion ≈ $13.40 Million |
0.204x | -32.31% |
| 2005-12-31 | Rs5.24 Billion ≈ $56.65 Million |
Rs1.58 Billion ≈ $17.05 Million |
0.301x | +77.53% |
| 2004-12-31 | Rs4.22 Billion ≈ $45.62 Million |
Rs715.33 Million ≈ $7.74 Million |
0.170x | -- |
About Sanofi India Limited
Sanofi India Limited manufactures and trades in drugs and pharmaceutical products in India, Singapore and internationally. The company offers pharmaceutical products in various therapeutic areas, such as diabetes, cardiology, anti-infectives, and central nervous system under the Lantus, Toujeo, Soliqua, Clexane, Amaryl, Cardace, Lasix, Lasilactone, Glimepiride, Cetapin, Targocid, Frisium, Targoci… Read more